Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.
Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AA, ElHaddad A, Othman TB, Bazarbachi A, Almohareb F, Alzahrani M, Alkindi SS, Alsharif F, Da'na W, Alhashmi H, Bekadja MA, Al-Shammari SH, El Quessar A, Satti TM, Aljohani N, Rasheed W, Ghavamzadeh A, Chaudhri N, Hashmi SK. Mohammed J, et al. Among authors: bazarbachi a. Hematol Oncol Stem Cell Ther. 2019 Sep;12(3):127-132. doi: 10.1016/j.hemonc.2018.12.003. Epub 2019 Jan 11. Hematol Oncol Stem Cell Ther. 2019. PMID: 30653940 Free article. Review.
Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: a single institution experience from the American University of Beirut.
Charafeddine KM, Hatoum HA, Otrock ZK, Mahfouz RA, Salem ZM, Shamseddine AI, Taher AT, El-Saghir NS, Bazarbachi A. Charafeddine KM, et al. Among authors: bazarbachi a. Hematol Oncol Stem Cell Ther. 2009;2(2):333-9. doi: 10.1016/s1658-3876(09)50021-0. Hematol Oncol Stem Cell Ther. 2009. PMID: 20118056 Free article. Clinical Trial.
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
Bazarbachi A, Azim HA, Alizadeh H, Aljurf M, Barista I, Chaudhri NA, Fahed Z, Fahmy OA, Ghavamzadeh A, Khalaf MH, Khatib S, Kutoubi A, Paydas S, Elayoubi HR, Zaatari G, Zawam HM, Zelenetz AD; MENA Lymphoma Regional Guidelines Committee. Bazarbachi A, et al. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S29-35. doi: 10.6004/jnccn.2010.0122. J Natl Compr Canc Netw. 2010. PMID: 20697129
Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.
Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M. Ahmed SO, et al. Among authors: bazarbachi a. Biol Blood Marrow Transplant. 2011 Sep;17(9):1352-61. doi: 10.1016/j.bbmt.2011.01.019. Epub 2011 Apr 1. Biol Blood Marrow Transplant. 2011. PMID: 21440654 Free PMC article.
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Rasheed W, Ghavamzadeh A, Hamladji R, Ben Othman T, Alseraihy A, Abdel-Rahman F, Elhaddad A, Alabdulaaly A, Dennison D, Ibrahim A, Bazarbachi A, Bekadja MA, Mohamed SY, Adil SN, Ahmed P, Benchekroun S, Ramzi M, Jarrar M, Alimoghaddam K, Hussain F, Hamidieh A, Aljurf M. Rasheed W, et al. Among authors: bazarbachi a. Hematol Oncol Stem Cell Ther. 2013 Mar;6(1):14-9. doi: 10.1016/j.hemonc.2013.04.001. Epub 2013 Apr 6. Hematol Oncol Stem Cell Ther. 2013. PMID: 23664600 Free article.
Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M, Nassar A, Hamidieh AA, Elhaddad A, Hamladji RM, Bazarbachi A, Ibrahim A, Ben Othman T, Abdel-Rahman F, Alseraihy A, Fahmy O, Hussein AA, Alabdulaaly A, Adil S, Alkindi SS, Bayoumy M, Dennison D, Bekadja MA, Redhouane AN, Rasheed W, AlSagheir A, Alsudairy R, Ladeb S, Benchekroun S, Ramzi M, Ahmed P, ElSolh H, Ahmed SO, Hussain F, Ghavamzadeh A. Aljurf M, et al. Among authors: bazarbachi a. Hematol Oncol Stem Cell Ther. 2015 Dec;8(4):167-75. doi: 10.1016/j.hemonc.2015.09.002. Epub 2015 Oct 1. Hematol Oncol Stem Cell Ther. 2015. PMID: 26452331 Free article.
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
Battipaglia G, Ruggeri A, Massoud R, El Cheikh J, Jestin M, Antar A, Ahmed SO, Rasheed W, Shaheen M, Belhocine R, Brissot E, Dulery R, Eder S, Giannotti F, Isnard F, Lapusan S, Rubio MT, Vekhoff A, Aljurf M, Legrand O, Mohty M, Bazarbachi A. Battipaglia G, et al. Among authors: bazarbachi a. Cancer. 2017 Aug 1;123(15):2867-2874. doi: 10.1002/cncr.30680. Epub 2017 Apr 7. Cancer. 2017. PMID: 28387928 Free article.
Trends in hematopoietic stem cell transplant activity in Lebanon.
Bazarbachi A, Zahreddine A, Massoud R, El Cheikh J, Hanna C, Nasr F, Abboud M, Ibrahim A. Bazarbachi A, et al. Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):315-320. doi: 10.1016/j.hemonc.2017.05.003. Epub 2017 Jun 13. Hematol Oncol Stem Cell Ther. 2017. PMID: 28641098 Free article.
393 results